NIH Board Chair Jack Leslie Questions Vaccine Clinic Launch
The chair of the NIH Clinical Center Research Hospital board argued that Robert F. Kennedy Jr.'s new clinic risks the institution's reputation without adding new funding or space.
By Ahmed Peterson ·

The board overseeing the National Institutes of Health's Clinical Center Research Hospital received a formal warning that a new vaccine injury clinic could affect the institution's standing. Jack Leslie, the board's chair, delivered the remarks during a recently scheduled meeting.
Leslie began the session with standard introductions before turning his attention to Health Secretary Robert F. Kennedy Jr. For approximately six minutes, he criticized the secretary's recent activities. Leslie warned that the anti-vaccine initiatives associated with the administration could tarnish the hospital's reputation. The facility is frequently referred to as the house of hope because it serves patients with rare conditions who have exhausted other treatment options.
The criticism centered on a surprise ribbon-cutting ceremony held at the hospital. Kennedy attended the event to open his signature vaccine injury clinic. A panel of individuals who claim they were injured by vaccines sat behind placards reading vaccine injured. They spoke with Kennedy and other high-ranking Trump administration officials present at the ceremony.
Leslie acknowledged that some members might prefer the board remain silent on the issue. He argued that staying quiet would constitute a failure of the group's advisory role. But I think that that would be a failing as an advisory board if we were silent, he said.
The chair clarified that his objection was not to the scientific study of vaccine harms. He stated that he has no concerns about researching potential injuries from vaccines. Serious reactions are rare, but real, he noted. He added that people who believe they have been injured should be taken seriously.
Hospital CEO Jonathan Green supported the view that the new clinic is not a major structural change. Green stated that the NIH has researched vaccine safety and efficacy for decades. He described the new clinic as just one more individual protocol at the hospital. The new clinic comes with no additional funding and no extra clinic space, according to the remarks from both the board chair and the chief executive.
The NIH already operates a center that studies vaccine injuries. Green emphasized that the research work continues. Leslie framed the issue as a matter of reputation for a hospital that serves vulnerable patients. Green presented the clinic as a modest addition to existing research activities.
Source: Ars Technica





